Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2014
05/01/2014US20140120128 Use of yscf, truncated yscf and yscf homologs as adjuvants
05/01/2014US20140120125 Vaccine composition comprising an inactivated chikungunya virus strain
05/01/2014US20140120124 Cell capable of expressing exogenous gitr ligand
05/01/2014US20140120121 Medicinal treatment of atopic inflammatory diseases
05/01/2014US20140120117 Treatment of tumors using specific anti-l1 antibody
05/01/2014US20140120116 Treatment of cancer using smad3 inhibitor
05/01/2014US20140120112 Therapeutics for age-related macular degeneration
05/01/2014US20140120111 Treatment of autoimmune disorders and infections using antagonists of sgk1 activity
05/01/2014US20140120107 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/01/2014US20140120104 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders
05/01/2014US20140120100 Compositions and methods for preventing erythropoietin-associated hypertension
05/01/2014US20140120097 Generation of new pancreatic beta cells
05/01/2014US20140120089 Antibodies to insulin-like growth factor i receptor
05/01/2014US20140120088 Agents for the treatment of tumors
05/01/2014US20140120086 Method for preparation of a high concentration liquid formulation of an antibody
05/01/2014US20140120085 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
05/01/2014US20140120084 Methods of administering beta7 integrin antagonists
05/01/2014US20140120082 Modulation of nkg2d
05/01/2014US20140120079 Compositions and Methods for Diagnosing and Treating Diabetic Micro Vascular Complications
05/01/2014US20140120035 RS7 Antibodies
05/01/2014CA2794051A1 New fusion proteins for the treatment of allergic diseases
04/2014
04/30/2014EP2725037A1 Monoclonal antibodies binding canine CD20
04/30/2014EP2725036A1 Recombinant anti-epidermal growth factor receptor antibody compositions
04/30/2014EP2725034A1 Carrier immunoglobulins and uses thereof
04/30/2014EP2725033A1 Method for producing protein preparation
04/30/2014EP2724728A1 Complexes of IL-15 and IL-15R alpha and uses thereof
04/30/2014EP2724727A1 Complexes of IL-15 and IL-15R alpha and uses thereof
04/30/2014EP2724726A1 Use of intranasally administered Pidotimod to enhance antigen-specific humoral and cell-mediated immune response
04/30/2014EP2723869A1 An il-15 and il-15r sushi domain based immunocytokines
04/30/2014EP2723855A2 Influenza virus mutants and uses therefor
04/30/2014EP2723386A1 An aqueous composition comprising a biological antigen and an acrylic acid polymer
04/30/2014EP2723382A1 Methods and compositions for modulating voltage-gated calcium channel function
04/30/2014EP2723381A2 Focused radiation for augmenting immune-based therapies against neoplasms
04/30/2014EP2723380A1 Light chain immunoglobulin fusion proteins and methods of use thereof
04/30/2014EP2723379A1 Anti-alpha synuclein binding molecules
04/30/2014EP2723378A1 Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
04/30/2014EP2723377A1 Anti-axl antibodies and uses thereof
04/30/2014EP2723376A1 Anti-axl antibodies and uses thereof
04/30/2014EP2723375A2 Materials and methods for modulating immune responses
04/30/2014EP2723374A1 Recombinant mistletoe lectin and use thereof as an adjuvant
04/30/2014EP2723373A2 Contiguous overlapping peptides for treatment of ragweed pollen allergy
04/30/2014EP2723372A2 Protection against dengue virus and prevention of severe dengue disease
04/30/2014EP2723371A1 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
04/30/2014EP2723365A1 Compositions and methods for the therapy and diagnosis of cancer
04/30/2014EP2723362A1 NKp46-MEDIATED NK CELL TUNING
04/30/2014EP2723361A1 Methods of treating chronic disorders with complement inhibitors
04/30/2014DE112012000439T5 Stammzellfaktor-Inhibitor Stem cell factor inhibitor
04/30/2014CN103764830A Composition comprising inhibitors of IRS-1 and of VEGF
04/30/2014CN103764825A Cancer treatment and/or prevention drug composition
04/30/2014CN103764817A Recombinant swine influenza virus and uses thereof
04/30/2014CN103764681A Bispecific antigen binding molecules
04/30/2014CN103764679A Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
04/30/2014CN103764678A c-Met antibody combinations
04/30/2014CN103764171A Tyrosine ligation process
04/30/2014CN103764164A Production of dense bodies (db) from hcmv-infected cells
04/30/2014CN103764160A Assays for influenza virus hemagglutinins
04/30/2014CN103764121A Liposomes having useful N:P ratio for delivery of RNA molecules
04/30/2014CN103757054A Recombinant replication-deficient adenovirus vector equine influenza (EI) genetic engineering vaccine and application thereof
04/30/2014CN103757032A Chimeric HCV (hepatitis C virus) vaccine taking influenza virus as carrier and preparation method thereof
04/30/2014CN103757026A Gene sequence and polypeptide of FGFR2b ectodomain and application thereof
04/30/2014CN103756977A gE- and gI-deleted porcine pseudorabies virus variant strain and use thereof
04/30/2014CN103756976A Diploid cell adaptive method of F genotype mumps viral strain MHM-19
04/30/2014CN103756974A Porcine epidemic diarrhea virus, and culture method and application thereof
04/30/2014CN103756942A Escherichia coli strain and dairy cow mastitis vaccine obtained by inactivating same
04/30/2014CN103755812A GM-CSF-HER2 recombinant protein, and preparation method and applications thereof
04/30/2014CN103755811A AFP recombinant protein, and in vitro high-efficiency recombination expression method
04/30/2014CN103755809A Antibodies for treating and diagnosing tumors expressing SLC34A2(TAT211=SEQID2)
04/30/2014CN103755808A Novel anti-alpha5beta1 antibodies and uses thereof
04/30/2014CN103755807A Specific binding agents to hepatocyte growth factor
04/30/2014CN103755805A Human monoclonal antibody with HIV-1 Env specificity
04/30/2014CN103751803A Interferon regulatory factor 9 (IRF9) and application of inhibitor thereof in cerebral apoplexy
04/30/2014CN103751783A Function of IRF1 in aortic constriction disease and application of inhibitor thereof
04/30/2014CN103751780A KIM-1 antibodies for treatment of TH2-mediated conditions
04/30/2014CN103751779A Poloxamer gel adjuvant for O-typed foot and mouth disease polypeptides
04/30/2014CN103751778A Application of 3'-deoxyadenosine to preparation of immunologic adjuvant for synergizing broad-spectrum vaccine
04/30/2014CN103751777A Diammonium glycyrrhizinate adjuvant and vaccine containing same
04/30/2014CN103751776A Oxidized astragalus mixture and application thereof
04/30/2014CN103751775A Ginsenoside-containing vegetable oil adjuvant and preparation method and application thereof
04/30/2014CN103751774A Recombinant cell line for stably expressing classical swine fever virus E2 protein, and applications of the same in preparation of subunit vaccines and diagnosis reagents of classical swine fever
04/30/2014CN103751773A Recombinant BHK cell line for stably expressing classical swine fever virus E0-E1-E2 protein, and applications of the same in preparation of vaccines and diagnosis reagents of classical swine fever
04/30/2014CN103751772A Method for preparing genotype F mumps attenuated live vaccine
04/30/2014CN103751771A Immunity-inducing agent
04/30/2014CN103103205B Gene for encoding recombinant porcine circovirus type 2 (PCV2) Cap protein and application of gene
04/30/2014CN102965345B Porcine parvovirus, vaccine composition and application thereof
04/30/2014CN102732544B A method for expelling a bacillus anthracis virulence large plasmid pXO1
04/30/2014CN102596219B Novel bacteriophage and antibacterial composition comprising the same
04/30/2014CN102448493B Treatment of insulin-resistant disorders
04/30/2014CN102443060B Anti-HPV (human papilloma virus) antibody and preparation method and application thereof
04/30/2014CN102380096B Medicine combination containing fusion protein for suppressing angiogenesis and application
04/30/2014CN102319426B Preparation method of specific tumor vaccine for removing regulatory T cells
04/30/2014CN102131523B Modified beta-lactoglobulins for immunotherapy of milk allergy
04/30/2014CN101925364B 14-3-3 antagonists for prevention and treatment of arthritis
04/30/2014CN101918565B Replication-defective arenavirus vectors
04/30/2014CN101875697B Design of novel anti-EGFR humanized antibody TGM10 and application thereof
04/30/2014CN101843897B Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
04/30/2014CN101724075B Remodeling and glycoconjugation of peptides
04/30/2014CN101500605B Use of Dll4 antagonists in treating local ischemic injury
04/30/2014CN101360826B Anti-alpha2 integrin antibodies and their uses
04/29/2014US8710202 Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity
04/29/2014US8710194 Single-chain variable fragment (scFv) able to recognize and bind CD99 human protein
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 1823